Adapting and validating the Autism Diagnostic Interview - Revised for use with deaf children and young people.

Autism Diagnostic Interview–Revised Autism Diagnostic Interview–Revised Deaf Adaptation British Sign Language Delphi consensus methodology autism spectrum disorder children deaf deaf culture gesture language modified

Journal

Autism : the international journal of research and practice
ISSN: 1461-7005
Titre abrégé: Autism
Pays: England
ID NLM: 9713494

Informations de publication

Date de publication:
02 2022
Historique:
pubmed: 17 7 2021
medline: 31 3 2022
entrez: 16 7 2021
Statut: ppublish

Résumé

Autism assessment processes need to improve for deaf children as they are currently being diagnosed later than their hearing counterparts and misdiagnosis can occur. We took one of the most commonly used parent developmental interviews for autism spectrum disorder the Autism Diagnostic Interview-Revised and adapted it using international expert advice. Modifications were proposed and agreed by the expert panel for 45% of items; the remaining 55% of items were unchanged. We then tested the revised version, adapted for deaf children (Autism Diagnostic Interview-Revised Deaf Adaptation), in a UK sample of 78 parents/carers of deaf children with autism spectrum disorder and 126 parents/carers with deaf children without autism spectrum disorder. When compared to National Institute for Health and Care Excellence guideline standard clinical assessments, the Autism Diagnostic Interview-Revised Deaf Adaptation diagnostic algorithm threshold scores could identify those deaf children with a definite diagnosis (true autism spectrum disorder positives) well (sensitivity of 89% (79%-96%)) and those deaf children who did not have autism spectrum disorder (true autism spectrum disorder negatives) well (specificity of 81% (70%-89%)). Our findings indicate that the Autism Diagnostic Interview-Revised Deaf Adaptation is likely to prove a useful measure for the assessment of deaf children with suspected autism spectrum disorder and that further research would be helpful.

Identifiants

pubmed: 34269085
doi: 10.1177/13623613211029116
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

446-459

Subventions

Organisme : Medical Research Council
ID : MR/K015435/1
Pays : United Kingdom

Auteurs

Barry Wright (B)

University of York, York, UK.
Leeds and York Partnership NHS Foundation Trust, UK.

Helen Phillips (H)

Leeds and York Partnership NHS Foundation Trust, UK.

Victoria Allgar (V)

University of York, York, UK.

Jennifer Sweetman (J)

Leeds and York Partnership NHS Foundation Trust, UK.

Rachel Hodkinson (R)

Leeds and York Partnership NHS Foundation Trust, UK.

Emily Hayward (E)

Leeds and York Partnership NHS Foundation Trust, UK.

Amelia Ralph-Lewis (A)

Leeds and York Partnership NHS Foundation Trust, UK.

Catarina Teige (C)

Leeds and York Partnership NHS Foundation Trust, UK.

Martin Bland (M)

Newcastle University, Newcastle, UK.

Ann Le Couteur (A)

Newcastle University, Newcastle, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH